Answer
It is licensed for certain adults with previously treated, locally advanced or metastatic non-small cell lung cancer carrying a KRAS G12C mutation.
Sources for this answer
- LUMYKRAS 240 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 3